home All News open_in_new Full Article

Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry

VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced the appointments of Greg Ciongoli and Robert E. Landry to the Company’s Board […]


today 4 d. ago attach_file Other

attach_file Culture
attach_file Other
attach_file Other
attach_file Economics
attach_file Other
attach_file Politics
attach_file Culture
attach_file Other
attach_file Culture
attach_file Culture
attach_file Other
attach_file Economics
attach_file Other
attach_file Other
attach_file Culture
attach_file Other
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Other


ID: 894351309
Add Watch Country

arrow_drop_down